HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
2018 · Annals of Oncology · 215 citations
https://doi.org/10.1093/annonc/mdy542
S
Shengxiang Ren
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
385
Papers
16.8K
Citations
59
h-index
190
i10-index
Shengxiang Ren is an academic researcher from Tongji University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 59, co-authored 328 publications.
ORCID: 0000-0001-8767-9850Papers by this author
worksConsensus for HER2 alterations testing in non-small-cell lung cancer
2022 · ESMO Open · 105 citations
https://doi.org/10.1016/j.esmoop.2022.100395
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
2019 · Journal of Hematology & Oncology · 104 citations
https://doi.org/10.1186/s13045-019-0762-1
Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis
2018 · BMC Cancer · 84 citations
https://doi.org/10.1186/s12885-018-4075-5
Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
2023 · Experimental Hematology and Oncology · 81 citations
https://doi.org/10.1186/s40164-023-00419-w
Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer
2018 · Cancer · 79 citations
https://doi.org/10.1002/cncr.31871
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat